Wockhardt Shares Soar 4% as Zaynich Shows 97% Clinical Efficacy
Shares of Wockhardt Ltd soared 4% on 13 January after the company’s drug Zaynich showed clinical efficacy of over 97% in treating critically ill patients...
Tag : Wockhardt ltd
Wockhardt Shares Skyrocketed 9% on Receiving Approval for Pneumonia Antibiotic
Shares of Wockhardt Ltd skyrocketed 9% on 3 January after the Indian pharma authority approved an oral antibiotic for the treatment of pneumonia. The Central...
Wockhardt Submits Fast-Acting Insulin to DCGI, Shares Jump 4%
Shares of Wockhardt Ltd. surged 4%, reaching a day’s high of Rs 1,126.50 on 16th October, after the company announced it had filed its fast-acting...
Wockhardt Shares Hit Upper Circuit as Investigational Drug Cures Meningitis, Up 5%
Shares of Wockhardt Ltd. rallied 5% to hit an upper circuit at Rs 1,005.70 on 19th September, after the company announced that its investigational drug,...
Wockhardt Looking to Complete Phase III Trials for Zaynich
The Indian pharma company, Wockhardt Ltd, on Wednesday, 29 May, said that the Phase III clinical trial for Zaynich (Zidebactam/Cefepime) is expected to be completed...
Morepen Laboratories Ltd Leads Gainers in ‘A’ Group
On the Bombay Stock Exchange (BSE), Jyothy Labs Ltd, Sun Pharma Advanced Research Company Ltd, Wockhardt Ltd and Ajanta Pharma Ltd are the other gainers...
Wockhardt Ltd Receives USFDA Approval For Cancer Treatment Drug
Wockhardt Ltd. announced that the drugmaker has received approval from the U.S. health regulator, USFDA, for the generic version of Gleevec used for the treatment...
